256 related articles for article (PubMed ID: 15709763)
1. Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.
Sunavala-Dossabhoy G; Van Dyke MW
Biochemistry; 2005 Feb; 44(7):2510-22. PubMed ID: 15709763
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial determination of sequence specificity for nanomolar DNA-binding hairpin polyamides.
Vashisht Gopal YN; Van Dyke MW
Biochemistry; 2003 Jun; 42(22):6891-903. PubMed ID: 12779344
[TBL] [Abstract][Full Text] [Related]
3. Sequence-specific DNA alkylation of novel tallimustine derivatives.
Marchini S; Cozzi P; Beria I; Geroni C; Capolongo L; D'Incalci M; Broggini M
Anticancer Drug Des; 1998 Apr; 13(3):193-205. PubMed ID: 9595033
[TBL] [Abstract][Full Text] [Related]
4. Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific.
Herzig MC; Trevino AV; Arnett B; Woynarowski JM
Biochemistry; 1999 Oct; 38(42):14045-55. PubMed ID: 10529251
[TBL] [Abstract][Full Text] [Related]
5. REPSA: general combinatorial approach for identifying preferred ligand-DNA binding sequences.
Van Dyke MW; Van Dyke N; Sunavala-Dossabhoy G
Methods; 2007 Jun; 42(2):118-27. PubMed ID: 17472894
[TBL] [Abstract][Full Text] [Related]
6. Identification of preferred distamycin-DNA binding sites by the combinatorial method REPSA.
Hardenbol P; Wang JC; Van Dyke MW
Bioconjug Chem; 1997; 8(5):617-20. PubMed ID: 9327123
[TBL] [Abstract][Full Text] [Related]
7. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
[TBL] [Abstract][Full Text] [Related]
8. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
Brooks N; McHugh PJ; Lee M; Hartley JA
Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
[TBL] [Abstract][Full Text] [Related]
9. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
11. Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies.
Martin C; Ellis T; McGurk CJ; Jenkins TC; Hartley JA; Waring MJ; Thurston DE
Biochemistry; 2005 Mar; 44(11):4135-47. PubMed ID: 15766241
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
[TBL] [Abstract][Full Text] [Related]
13. Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
Marchini S; CirĂ² M; Gallinari F; Geroni C; Cozzi P; D'Incalci M; Broggini M
Br J Cancer; 1999 Jun; 80(7):991-7. PubMed ID: 10362106
[TBL] [Abstract][Full Text] [Related]
14. Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation.
Turner PR; Ferguson LR; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):61-70. PubMed ID: 10363028
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
18. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
19. A novel assay to determine the sequence preference and affinity of DNA minor groove binding compounds.
Thomas R; Gonzalez C; Roberts C; Botyanszki J; Lou L; Michelotti EF
Nucleic Acids Res; 2004 Jan; 32(1):e8. PubMed ID: 14718553
[TBL] [Abstract][Full Text] [Related]
20. Selective DNA interaction of the novel distamycin derivative FCE 24517.
Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]